AION Labs Information

AION Labs is a venture studio dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development. It is a unique partnership formed by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS. AION Labs combines deep pharmaceutical R&D expertise with cutting-edge AI to create de-risked, industry-aligned ventures. Through its co-development model, startups gain early access to pharma insights, R&D champions, and real-world validation opportunities — alongside structured company-building support and funding. In three years, AION Labs has launched nine companies, delivered multiple pharma pilots and collaborations across drug R&D, and achieved strong market validation through follow-on funding, up-rounds, and a strategic M&A.